Professional Documents
Culture Documents
Alcohol Related Liver Disease
Alcohol Related Liver Disease
Alcohol Related Liver Disease
Definition
Alcoholic liver disease (ALD) is a clinical and histological spectrum of
disease which includes fatty liver (FL) at one extreme and alcoholic cirrhosis
(AC) at the other.
Female sex
Genetics
Advanced age
Induction of liver enzymes by drugs
Co-existent viral hepatitis especially hepatitis C
Pathophysiology
The development of ALD is multifactorial. Alcohol is metabolised in the liver
by progressive enzymatic oxidation to form acetaldehyde then acetate.
Note the first oxidation of alcohol to acetaldehyde may occur via one of
three pathways:
Factor Notes
NADH There are 3 enzymes involved in the conversion of ethanol to acetaldehyde, of
which alcohol dehydrogenase (ADH) is the primary enzyme.
The NADH:NAD+ ratio controls a number of redox reactions within cells and its
increase can lead to cellular metabolic dysregulation including increased fatty acid
and triglyceride synthesis. NADH itself is metabolised by a series of oxidations
which increases the oxygen demand of hepatocytes and can lead to cellular hypoxia
Factor Notes
if this oxygen demand is not met
Acetate Acetate may be oxidised to form CO2 or metabolized to acetyl CoA. Acetyl CoA is
a substrate for several lipids. Acetate therefore promotes cholesterol biosynthesis
and fatty liver transformation
Acetaldehyd There are several mechanisms by which acetaldehyde damages liver cells:
e
Genetics Several enzyme systems are involved in the metabolism of alcohol. Polymorphism's
of these systems (ALDH2, CYPE21 and cytokines TNF, IL1, IL10)
can increase hepatic damage via enhancing the pathological effects outlined above
Hepatitis C
Hepatitis C infection (HCV) and alcohol have an additive deleterious effect
on the liver. Alcohol is thought to suppress the immune response to HCV
and reduce viral clearance.
Those with early liver damage who are symptomatic will often have non-
specific symptoms, such as abdominal discomfort, vomiting or anxiety. It is
not uncommon for these patients to first present to the ED following falls
or injuries sustained whilst intoxicated.
Patients with alcoholic hepatitis will typically be unwell with pyrexia and
anorexia. Liver function tests will be deranged and they may show clinical
signs of chronic liver damage.
Patients with advanced liver disease may show signs of portal hypertension
and cirrhosis. These include:
Ascites
Varices (rectal and oesophageal)
Umbilical varices (caput medusae)
Jaundice
Cutaneous signs including spider angiomas and palmar erythema
Encephalopathy
Bleeding (impaired synthetic function reduces clotting factors)
CAGE questionnaire
FAST (Fast alcohol screening tool)
PAT (Paddington Alcohol Test)
AUDIT (Alcohol Use Disorders Identification Test) or AUDIT PC
Score Interpretation
0-7 indicates low-risk
8-15 indicates increasing risk
16-19 indicates higher risk
20 or more indicates possible dependence
Investigations
GGT is often raised but has low sensitivity and specificity. Albumin may be
low due to impaired synthetic function.
Management
Advice:
Thiamine administration:
Thiamine should be given to all ALD patients who attend the ED.
Thiamine should ideally be administered before a glucose load to
prevent triggering Wernicke's
Thiamine is poorly absorbed orally in dependent alcohol drinkers so
should ideally be given parenterally.
Multivitamins are often co-prescribed given these patient's are at
high risk of nutritional deficiency. Magnesium deficiency is common
and magnesium levels should be checked and supplemented of
appropriate.
Withdrawal:
Management of complications
There are a number of complications that may arise from ALD. These
include:
Intoxication and coma
Encephalopathy
Oesophageal varices & massive haemorrhage
Ascites and liver synthetic function derangement
Hypoglycaemia
Coagulopathy
Exam questions often ask about Wernicke's triad of altered mental status,
ataxic gait and ophthalmoplegia. In real life this triad is only present in
around 10% of patient's with Wernicke's.